ArticleNature communications2026
TUSCO: benchmarking transcriptome reconstruction with endogenous single-isoform controls.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Handling biological replicates in long-read RNA sequencing data by joining or not joining.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Long-read sequencing (LRS) platforms, such as Oxford Nanopore and Pacific Biosciences, enable comprehensive transcriptome analysis but face challenges such as sequencing errors, sample quality variability, and library preparation biases. Current benchmarking approaches address these issues insufficiently: BUSCO assesses transcriptome completeness using conserved single-copy orthologous genes but can misinterpret alternative splicing as gene duplications, while SIRV spike-ins and ERCCs oversimplify real sample complexity, neglecting RNA degradation and RNA-extraction artifacts, thus inflating performance metrics. Simulation algorithms are limited in their ability to recapitulate the complexity of real samples. To overcome these limitations, we introduce the Transcriptome Universal Single-isoform COntrol (TUSCO) benchmarking framework, centered on a curated TUSCO gene set of genes lacking alternative isoforms that can be confidently treated as an internal ground truth. The TUSCO evaluation quantifies precision by identifying reconstructed transcripts that deviate from reference annotations and quantifies sensitivity by verifying detection completeness in human and mouse samples. Masking TUSCO gene set transcripts and replacing them with modified splice variants in the annotation creates a TUSCO-novel challenge that assesses reconstruction of the true, now-unannotated isoforms. Our validation demonstrates that TUSCO metrics provide accurate and reliable benchmarking without external controls, significantly improving quality control standards for transcriptome reconstruction using LRS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.